Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Gastric emptying and symptoms of bulimia nervosa: effect of a prokinetic agent.

Devlin MJ, Kissileff HR, Zimmerli EJ, Samuels F, Chen BE, Brown AJ, Geliebter A, Walsh BT.

Physiol Behav. 2012 May 15;106(2):238-42. doi: 10.1016/j.physbeh.2012.02.009. Epub 2012 Feb 14.

2.
4.

Ghrelin stimulates gastric emptying and hunger in normal-weight humans.

Levin F, Edholm T, Schmidt PT, Grybäck P, Jacobsson H, Degerblad M, Höybye C, Holst JJ, Rehfeld JF, Hellström PM, Näslund E.

J Clin Endocrinol Metab. 2006 Sep;91(9):3296-302. Epub 2006 Jun 13.

PMID:
16772353
5.
6.

Delayed postprandial gastric emptying and impaired gallbladder contraction together with elevated cholecystokinin and peptide YY serum levels sustain satiety and inhibit hunger in healthy elderly persons.

Di Francesco V, Zamboni M, Dioli A, Zoico E, Mazzali G, Omizzolo F, Bissoli L, Solerte SB, Benini L, Bosello O.

J Gerontol A Biol Sci Med Sci. 2005 Dec;60(12):1581-5.

PMID:
16424292
7.

Erythromycin effects on gastric emptying, antral motility and plasma motilin and pancreatic polypeptide concentrations in anorexia nervosa.

Stacher G, Peeters TL, Bergmann H, Wiesnagrotzki S, Schneider C, Granser-Vacariu GV, Gaupmann G, Kugi A.

Gut. 1993 Feb;34(2):166-72.

8.

Postprandial cholecystokinin release and gastric emptying in patients with bulimia nervosa.

Devlin MJ, Walsh BT, Guss JL, Kissileff HR, Liddle RA, Petkova E.

Am J Clin Nutr. 1997 Jan;65(1):114-20.

PMID:
8988922
9.

Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients.

Gonlachanvit S, Hsu CW, Boden GH, Knight LC, Maurer AH, Fisher RS, Parkman HP.

Dig Dis Sci. 2003 Mar;48(3):488-97.

PMID:
12757160
10.

Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers.

Verhagen MA, Samsom M, Maes B, Geypens BJ, Ghoos YF, Smout AJ.

Aliment Pharmacol Ther. 1997 Dec;11(6):1077-86.

11.

Erythromycin enhances solid-phase gastric emptying in induced-hyperglycemia in patients with truncal vagotomy and pyloroplasty.

Petrakis IE, Vrachassotakis N, Vassilakis SJ, Sciacca V, Chalkiadakis G.

Dig Dis Sci. 2000 May;45(5):937-45.

PMID:
10795758
12.

Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes.

Ozaki K, Monnai M, Onoma M, Muramatsu H, Yogo K, Watanabe T, Oda Y, Katagiri K, Arakawa H, Itoh Z, Omura S, Takanashi H.

J Diabetes Complications. 2008 Sep-Oct;22(5):339-47. doi: 10.1016/j.jdiacomp.2007.03.005. Epub 2008 Apr 16.

PMID:
18413164
13.

Different effects of cholestyramine on postprandial secretions of cholecystokinin and peptide YY in women with bulimia nervosa.

Rigamonti AE, Sartorio A, Scognamiglio P, Bini S, Monteleone AM, Mastromo D, Marazzi N, Cella SG, Monteleone P.

Neuropsychobiology. 2014;70(4):228-34. doi: 10.1159/000368160. Epub 2014 Dec 20.

PMID:
25592490
14.

Altered ghrelin and peptide YY responses to meals in bulimia nervosa.

Kojima S, Nakahara T, Nagai N, Muranaga T, Tanaka M, Yasuhara D, Masuda A, Date Y, Ueno H, Nakazato M, Naruo T.

Clin Endocrinol (Oxf). 2005 Jan;62(1):74-8.

PMID:
15638873
15.
16.
17.

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial.

Talley NJ, Verlinden M, Snape W, Beker JA, Ducrotte P, Dettmer A, Brinkhoff H, Eaker E, Ohning G, Miner PB, Mathias JR, Fumagalli I, Staessen D, Mack RJ.

Aliment Pharmacol Ther. 2000 Dec;14(12):1653-61.

18.

Hyperglycemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in healthy subjects.

Petrakis IE, Kogerakis N, Vrachassotakis N, Stiakakis I, Zacharioudakis G, Chalkiadakis G.

Abdom Imaging. 2002 May-Jun;27(3):309-14.

PMID:
12173362
19.

Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people.

Vazquez Roque MI, Camilleri M, Stephens DA, Jensen MD, Burton DD, Baxter KL, Zinsmeister AR.

Gastroenterology. 2006 Dec;131(6):1717-24. Epub 2006 Oct 15.

PMID:
17087952
20.

Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations.

Ellrichmann M, Kapelle M, Ritter PR, Holst JJ, Herzig KH, Schmidt WE, Schmitz F, Meier JJ.

J Clin Endocrinol Metab. 2008 Oct;93(10):3995-8. doi: 10.1210/jc.2008-0924. Epub 2008 Jul 22.

PMID:
18647814
Items per page

Supplemental Content

Write to the Help Desk